Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells
Masahito Shimizu, Masumi Suzui, Atsuko Deguchi, et al.
The Journal of Biological Chemistry
|
April 20, 2010
LKB1 suppresses p21-activated kinase-1 (PAK1) by phosphorylation of Thr109 in the p21-binding domain
Atsuko Deguchi, Hiroyuki Miyoshi, Yasushi Kojima, et al.
Journal of Visualized Experiments : Jove
|
March 19, 2019
Lung Tumor Cell Recruitment Assay
Takeshi Tomita, Katsuaki Ieguchi, Atsuko Deguchi, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization
Danhua Xiao, Atsuko Deguchi, Gregg G Gundersen, et al.
Molecular Cancer Therapeutics
|
December 21, 2002
Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G
Atsuko Deguchi, Jae-Won Soh, Han Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Jin T E Lim, et al.
Journal of Experimental Therapeutics & Oncology
|
January 19, 2006
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Andrew K Joe, et al.
Journal of Experimental Therapeutics & Oncology
|
November 21, 2002
Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction
Muneyuki Masuda, Masumi Suzui, Jin T E Lim, et al.
Cancer Science
|
August 13, 2009
Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/- mice
Hiroyuki Miyoshi, Atsuko Deguchi, Masayuki Nakau, et al.
Japanese Journal of Cancer Research : Gann
|
April 3, 2002
The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil
Muneyuki Masuda, Satoshi Toh, Koji Koike, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2004
Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells
Masahito Shimizu, Masumi Suzui, Atsuko Deguchi, et al.
The Journal of Biological Chemistry
|
April 20, 2010
LKB1 suppresses p21-activated kinase-1 (PAK1) by phosphorylation of Thr109 in the p21-binding domain
Atsuko Deguchi, Hiroyuki Miyoshi, Yasushi Kojima, et al.
Journal of Visualized Experiments : Jove
|
March 19, 2019
Lung Tumor Cell Recruitment Assay
Takeshi Tomita, Katsuaki Ieguchi, Atsuko Deguchi, et al.
Molecular Cancer Therapeutics
|
January 25, 2006
The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization
Danhua Xiao, Atsuko Deguchi, Gregg G Gundersen, et al.
Molecular Cancer Therapeutics
|
December 21, 2002
Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G
Atsuko Deguchi, Jae-Won Soh, Han Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2005
(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Jin T E Lim, et al.
Journal of Experimental Therapeutics & Oncology
|
January 19, 2006
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells
Masahito Shimizu, Atsuko Deguchi, Andrew K Joe, et al.
Journal of Experimental Therapeutics & Oncology
|
November 21, 2002
Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction
Muneyuki Masuda, Masumi Suzui, Jin T E Lim, et al.
Cancer Science
|
August 13, 2009
Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/- mice
Hiroyuki Miyoshi, Atsuko Deguchi, Masayuki Nakau, et al.
Japanese Journal of Cancer Research : Gann
|
April 3, 2002
The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil
Muneyuki Masuda, Satoshi Toh, Koji Koike, et al.
Page
of 3